# IRINOTECAN HYDROCHLORIDE
> **ANDA212993** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2019-11-18
## Drug
- **FDA Application Number:** ANDA212993
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IRINOTECAN HYDROCHLORIDE
- **Generic name:** IRINOTECAN HYDROCHLOIDE
- **Active ingredients:** IRINOTECAN HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** BluePoint Laboratories
- **First approval:** 2019-11-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212993)
---
*AI Analytics · CC0 1.0*